Two Sigma Investments’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$254K	Sell	317,400 -682,109	-68%	-$790K	﹤0.01%	4169
2025 Q4	$1.3M	Buy	999,509 +307,230	+44%	+$379K	﹤0.01%	2747
2025 Q3	$872K	Sell	692,279 -248,303	-26%	-$394K	﹤0.01%	2671
2025 Q2	$1.95M	Sell	940,582 -112,399	-11%	-$230K	﹤0.01%	1854
2025 Q1	$2.32M	Buy	1,052,981 +62,812	+6%	+$122K	0.01%	1644
2024 Q4	$1.51M	Sell	990,169 -411,906	-29%	-$668K	﹤0.01%	1906
2024 Q3	$2.79M	Buy	1,402,075 +295,639	+27%	+$706K	0.01%	1462
2024 Q2	$3.87M	Buy	1,106,436 +1,025,872	+1,273%	+$3.15M	0.01%	1128
2024 Q1	$223K	Buy	+80,564	New	+$203K	﹤0.01%	2672
2023 Q3	–	Sell	-36,500	Closed	-$42.3K	–	3066
2023 Q2	$42.3K	Sell	36,500 -112,000	-75%	-$200K	﹤0.01%	2844
2023 Q1	$224K	Sell	148,500 -124,581	-46%	-$312K	﹤0.01%	2520
2022 Q4	$683K	Buy	273,081 +120,863	+79%	+$389K	﹤0.01%	1885
2022 Q3	$642K	Buy	152,218 +45,163	+42%	+$177K	﹤0.01%	1659
2022 Q2	$299K	Buy	+107,055	New	+$430K	﹤0.01%	2027
2020 Q2	–	Sell	-116,226	Closed	-$1.36M	–	3240
2020 Q1	$1.36M	Sell	116,226 -17,757	-13%	-$334K	0.01%	1202
2019 Q4	$3.15M	Buy	+133,983	New	+$2.96M	0.01%	1248
2018 Q3	–	Sell	-8,780	Closed	-$341K	–	3430
2018 Q2	$341K	Buy	+8,780	New	+$280K	﹤0.01%	2871

Other funds holding HRTX